Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30513710 | 1.00 | HPGD (0.48) | HPGDL3MBTL1ALDH1A1NPSR1USP2 | |
| SCHEMBL518750 | 0.79 | NPSR1 (0.40) | HPGDL3MBTL1ALDH1A1NPSR1USP2 | |
| SCHEMBL22570604 | 0.78 | LTA4H (0.44) | HPGD | |
| SCHEMBL7026197 | 0.78 | GSTP1 (0.41) | HPGDALDH1A1NPSR1POLBMAPT | |
| SCHEMBL23004831 | 0.77 | HPGD (0.56) | HPGDL3MBTL1ALDH1A1NPSR1POLB | |
| SCHEMBL9806313 | 0.76 | NPSR1 (0.44) | HPGDL3MBTL1ALDH1A1NPSR1USP2 | |
| SCHEMBL5320056 | 0.73 | ALDH1A1 (0.52) | ALDH1A1NPSR1USP2CXCR3TAAR1 | |
| SCHEMBL1399903 | 0.73 | ALDH1A1 (0.50) | HPGDL3MBTL1ALDH1A1NPSR1USP2 | |
| SCHEMBL8786441 | 0.73 | ALDH1A1 (0.39) | HPGDALDH1A1NPSR1USP2POLB | |
| SCHEMBL111084 | 0.72 | ALDH1A1 (0.49) | HPGDL3MBTL1ALDH1A1NPSR1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138121-A1 | SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | CHEVRON U S A INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12269018-B2 | Platinum-sulfur-based shell catalyst, production and use thereof in the dehydrogenation of hydrocarbons | CLARIANT INTERNATIONAL LTD (CH) | 2025-04-08 | — | — | US | disclosed |
| WO-2025042907-A1 | SULFIDATED NOBLE METAL ON METAL DOPED SUPPORT AS A HYDROGENATION AND DEHYDROGENATION CATALYST | CHEVRON U.S.A. INC. (US) | 2025-02-27 | — | — | WO | disclosed |
| US-20250065311-A1 | SULFIDATED NOBLE METAL ON METAL DOPED SUPPORT AS A HYDROGENATION AND DEHYDROGENATION CATALYST | CHEVRON USA INC (US) | 2025-02-27 | — | — | US | disclosed |
| CN-111989156-B | Shell catalyst based on platinum-sulphur, production and use in hydrocarbon dehydrogenation | 科莱恩国际有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20210077984-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | CLARIANT INTERNATIONAL LTD (CH) | 2021-03-18 | — | — | US | disclosed |
| EP-3781307-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | Clariant International Ltd (CH) | 2021-02-24 | — | — | EP | disclosed |
| CN-111989156-A | Platinum-sulfur based shell catalysts, their production and use in the dehydrogenation of hydrocarbons | 科莱恩国际有限公司 | 2020-11-24 | — | — | CN | disclosed |
| WO-2019201706-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | CLARIANT INTERNATIONAL LTD (CH) | 2019-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138121-A1 | SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | NUDC, SOD1, TIMM10 | HPGD 1516/4885L3MBTL1 1106/4885ALDH1A1 1139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.